Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|July 5, 2021
Challenges in Treating Chlamydia trachomatis, Including Rectal Infections: Is It Time to Go Back to Doxycycline?S Lena Kang-Birken
Pharmacotherapy|October 27, 2006
Mycobacterium szulgai in a patient with advanced acquired immunodeficiency syndrome: an unusual pathogen with unusual multidrug resistanceS Lena Kang-Birken, John G Prichard
Journal of the International Association of Providers of AIDS Care|February 26, 2019
HIV Viral Rebound Due to a Possible Drug-Drug Interaction between Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide and Calcium-Containing Products: Report of 2 CasesS Lena Kang-Birken, Dena El-Sayed, John Prichard
Pharmacotherapy|March 26, 2010
Oral doxycycline for treatment of neurosyphilis in two patients infected with human immunodeficiency virusS Lena Kang-Birken, Uldine Castel, John G Prichard
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 21, 2022
Impact of a pharmacy department-wide transitions-of-care program on inappropriate oral antibiotic prescribing at hospital dischargeSarah M Halcomb, Arianne Johnson, S Lena Kang-Birken
Infection Control and Hospital Epidemiology|June 29, 2019
Role of rapid diagnostics for viral respiratory infections in antibiotic prescribing decision in the emergency departmentJing Li, S Lena Kang-Birken, Samantha K Mathews, et al.
Pharmacy (Basel, Switzerland)|September 22, 2022
Assessing Preceptor and Student Perceptions of Remote Advanced Pharmacy Practice Experience Learning during the COVID-19 PandemicS Lena Kang-Birken, Elaine J Law, Yong S K Moon, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 5, 2021
Adapting pharmacy experiential education during COVID-19: Innovating remote preceptor resources, tools, and patient care delivery beyond virtual meetingsElaine Law, Marie C Scott, Yong S K Moon, et al.
Microbiology Spectrum|October 3, 2022
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumanniiSara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Microbiology Spectrum|March 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving EnterobacteralesSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Pageof 2